Invention Grant
- Patent Title: Polymorphism of thrombospondin-1 as a biomarker for susceptibility to dry eye
-
Application No.: US14774044Application Date: 2014-03-14
-
Publication No.: US10093979B2Publication Date: 2018-10-09
- Inventor: Sharmila Masli
- Applicant: TRUSTEES OF BOSTON UNIVERSITY
- Applicant Address: US MA Boston
- Assignee: Trustees of Boston University
- Current Assignee: Trustees of Boston University
- Current Assignee Address: US MA Boston
- Agency: Nixon Peabody LLP
- Agent Ronald I. Eisenstein
- International Application: PCT/US2014/027343 WO 20140314
- International Announcement: WO2014/152440 WO 20140925
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/6883

Abstract:
Embodiments of the invention relate to single nucleotide polymorphisms (SNPs) in Thrombospondin 1 gene (THB-S1) that are herein linked to an increased risk for dry eye (also known as keratoconjunctivitis). The polymorphisms disclosed herein are directly useful for the diagnosis of an increased risk for dry eye, as well as for the determination of patient treatment pre- and post-surgery (e.g. pre and post refractive eye surgery) or in a patient having a condition associate with dry eye (e.g. diabetes, lupus, scleroderma, Sjogren's syndrome, thyroid disorders, vitamin A deficiency, and rheumatoid arthritis). Computer systems and medium are also enclosed. The SNPs can be present in unique combinations, or as specific haplotypes indicative of dry eye. The SNPs linked to an increased risk for dry eye include rs1478604, rs2228261, and rs2292305.
Public/Granted literature
- US20160024580A1 POLYMORPHISM OF THROMBOSPONDIN-1 AS A BIOMARKER FOR SUSCEPTABILTIY TO DRY EYE Public/Granted day:2016-01-28
Information query